DRI Healthcare Trust Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	188.92	184.71	158.91	87.27	79.86
Other Revenue	2.89	2.27	7.37	5.76	1.91
Revenue	191.81	186.99	166.28	93.03	81.77
Revenue Growth (YoY)	2.58%	12.45%	78.73%	13.78%	-
Gross Profit	191.81	186.99	166.28	93.03	81.77
Selling, General & Admin	14.01	20.29	49.64	9.19	9.6
Other Operating Expenses	10.39	7.86	4.11	4.29	5.41
Operating Expenses	138.34	140.02	146.62	74.2	57.33
Operating Income	53.47	46.97	19.66	18.83	24.44
Interest Expense	-39.7	-34.91	-26.5	-6.63	-2.24
Currency Exchange Gain (Loss)	-	-	-	-	0.08
Other Non Operating Income (Expenses)	-	-1.58	-2.57	-1.25	-0.72
EBT Excluding Unusual Items	13.78	10.49	-9.41	10.95	21.56
Gain (Loss) on Sale of Investments	2.03	-0.77	-	-	-
Gain (Loss) on Sale of Assets	-	-	110.12	-	-
Asset Writedown	-18.62	-15.26	-9.22	-	-
Other Unusual Items	-48.18	2.18	-	-	-
Pretax Income	-51	-3.36	91.5	10.95	21.56
Income Tax Expense	-0.53	-	-	-	-
Net Income	-50.47	-3.36	91.5	10.95	21.56
Net Income to Common	-50.47	-3.36	91.5	10.95	21.56
Net Income Growth	-	-	735.35%	-49.20%	-
Shares Outstanding (Basic)	56	56	44	39	35
Shares Outstanding (Diluted)	56	56	45	39	35
Shares Change (YoY)	-1.07%	26.26%	15.63%	11.36%	-
EPS (Basic)	-0.91	-0.06	2.06	0.28	0.62
EPS (Diluted)	-0.91	-0.06	2.05	0.28	0.62
EPS Growth	-	-	632.14%	-54.84%	-
Free Cash Flow	108.96	155.41	76.38	76.86	91.86
Free Cash Flow Per Share	1.96	2.76	1.71	1.99	2.65
Dividend Per Share	0.400	0.340	0.300	0.300	0.167
Dividend Growth	17.65%	13.33%	-	79.96%	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	27.88%	25.12%	11.83%	20.24%	29.89%
Profit Margin	-26.31%	-1.80%	55.03%	11.77%	26.37%
Free Cash Flow Margin	56.81%	83.12%	45.94%	82.62%	112.35%
EBITDA	155.44	149.83	106.65	78.07	66.28
EBITDA Margin	81.03%	80.13%	64.14%	83.91%	81.05%
D&A For EBITDA	101.97	102.87	86.98	59.23	41.84
EBIT	53.47	46.97	19.66	18.83	24.44
EBIT Margin	27.88%	25.12%	11.83%	20.24%	29.89%
Revenue as Reported	198.59	186.75	166.28	93.03	81.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.